1st Edition
Therapeutic Platform of Bioactive Lipids Focus on Cancer
PART I: CHEMISTRY OF BIOACTIVE LIPIDS
1. Ceramide: A Sphingolipidic Weapon Against Cancer
Suvadeep Mal, Udita Malik, Suman Das, and Sudhir Kumar Paidesetty
2. Lipoxins: Emerging Players in the Resolution of Cancer
Rati Kailash Prasad Tripathi
3. Role of Resolvins in Treatment of Cancer as a Bioactive Lipid
Suman Das, Suvadeep Mal, and Udita Malik
4. Sphingosine-1-Phosphate: An Important Target to Fight Against Cancer
Udita Malik, Suvadeep Mal, Suman Das, and Dilip Kumar Pal
PART II: FORMULATION BASED ON BIOACTIVE LIPIDS
5. Bioactive Lipids for the Treatment of Cancer
Biswajit Basu, Tiyas Pal, Swarupananda Mukherjee, and Bhupendra G. Prajapati
6. Role of Exosomes as Natural Conveyors of Bioactive Lipids in Cancer
Sapna Jain and Jonathan Pillai
PART III: MECHANISM OF BIOACTIVE LIPIDS
7. Identification of Bioactive Lipid Drug Targets by Computational Techniques
Aakriti Garg, Ruchika Sharma, Santanu Kaity and Anoop Kumar
8. Metabolism of Lipids in Malignant Solid Tumors under Hypoxia and Drug Targets
Lakhveer Singh, Sakshi Bajaj, Gaurav Kaithwas, and Manjusha Choudhary
9. Novel Targeting Therapy for Colorectal Cancer with Special Emphasis on KRAS and PI3K Pathway
Ram Kumar Sahu, Aseem Setia, and Jiyauddin Khan
10. Role of Lipid-Soluble Bioactive Substance from Avocado for Inhibition of Prostate and Other Cancers
Dilipkumar Pal and Khushboo Raj
11. Role of Lipopolysaccharide in the Pathogenesis of Cancer
Siddhant Mitra and Sugato Banerjee
12. Role of Lysophosphatidic Acid on Cancer
Dilipkumar Pal and Supriyo Saha
13. Role of Omega-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Cancer Hacks
Souvik Mukherjee, Gaurav Kaithwas, Manjari Singh, and Subhasis Banerjee
Biography
Manjari Singh, PhD, is currently working as an Assistant Professor in the Department of Pharmaceutical Sciences, Assam Central University, Silchar, India. She received her PhD degree from Babasaheb Bhimrao Ambedkar University, Lucknow, India. During the doctoral study, she has identified some novel prolyl-hydroxylase activators as potent breast cancer therapeutics. Her research area is focused on the regulation of hypoxia in the tumor microenvironment, in silico-based drug discovery, and in-vitro/in vivo disease models in cancer. Dr. Singh is a member of multiple editor/reviewer boards of different reputed journals and is a recipient of the various research grant. She has published 37 journal papers (authored/co-authored), four book chapters to date, and also been involved in pharmacology teaching to the graduate student.
